Variables | Cases | Controls | ORa | 95% CI | P-value | ORb | 95% CI | P-value | ||
---|---|---|---|---|---|---|---|---|---|---|
n | % | n | % | |||||||
O. viverrini-IgG antibody | 0.02 | 0.01 | ||||||||
OD ≤ 0.24 | 32 | 18.8 | 109 | 31.0 | 1.0 | 1.0 | ||||
OD > 0.24 | 138 | 81.2 | 243 | 69.0 | 2.0 | 1.3–3.1 | 2.1 | 1.2–3.9 | ||
IL-1B C-511 T polymorphisms | 0.05 | 0.22 | ||||||||
CC | 40 | 23.6 | 69 | 19.5 | 1.0 | 1.0 | ||||
CT | 99 | 58.2 | 187 | 52.8 | 0.9 | 0.6–1.4 | 0.8 | 0.4–1.5 | ||
TT | 31 | 18.2 | 98 | 27.7 | 0.5 | 0.3–0.9 | 0.4 | 0.2–0.8 | ||
TNF-A G-308A polymorphisms | 0.19 | 0.30 | ||||||||
GG | 105 | 61.8 | 244 | 68.8 | 1.0 | 1.0 | ||||
GA | 29 | 17.1 | 58 | 16.3 | 1.1 | 0.7–1.8 | 1.2 | 0.6–2.4 | ||
AA | 36 | 21.1 | 53 | 14.9 | 1.6 | 1.0–2.6 | 1.7 | 0.9–3.3 |